AZD8205
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD8205, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies [Phase 1, Phase 2]